目的探讨长春西汀联合依达拉奉治疗急性脑梗死的临床效果及对患者神经功能恢复的影响。方法选取2013年1月至2016年12月于本院就诊的急性脑梗死患者232例为研究对象。根据随机数表法将入选患者分为对照组(102例)和观察组(130例),所有患...目的探讨长春西汀联合依达拉奉治疗急性脑梗死的临床效果及对患者神经功能恢复的影响。方法选取2013年1月至2016年12月于本院就诊的急性脑梗死患者232例为研究对象。根据随机数表法将入选患者分为对照组(102例)和观察组(130例),所有患者均行抗血小板聚集、降脂固斑、控制血压、维持水电解质平衡等常规治疗。对照组患者注射依达拉奉,观察组患者在对照组治疗基础上加用长春西汀治疗。治疗1个疗程后比较两组患者脑血流灌注评价指标和血清学指标,出院2个月后随访比较两组患者美国国立卫生研究院卒中量表(National Institute of Health Stroke Scale,NIHSS)评分、格拉斯哥昏迷评分(Glasgow coma score,GCS)及临床疗效。结果治疗后,两组患者NIHSS评分较治疗前均显著降低(P<0.05),GCS较治疗前均显著升高(P<0.05);观察组患者NIHSS评分显著低于对照组(P<0.05),GCS显著高于对照组(P<0.05)。治疗后观察组患者脑血流量(cerebral blood flow,CBF)和脑血容量(cerebral blood volume,CBV)较对照组均显著增加(P<0.001),脑血流平均通过时间(mean transit time,MTT)较对照组显著缩短(P<0.001),神经生长相关蛋白43(growth-associated protein 43,GAP-43)、基质金属蛋白酶(matrix metalloproteinases,MMP)-2、MMP-9、血栓调节蛋白(thrombomodulin,TM)及血小板因子4(platelet factor 4,PF4)含量均显著低于对照组(P<0.05,P<0.001)。观察组患者治疗总有效率显著高于对照组(P<0.05)。结论长春西汀联合依达拉奉治疗急性脑梗死,能够明显改善患者NIHSS评分和GCS,显著增加CBF和CBV,有效缩短脑血流MTT,降低GAP-43、MMP-2、MMP-9、TM、PF4含量,临床治疗效果显著。展开更多
Objective:Augmented renal clearance(ARC),in contrast to renal dysfunction,refers to enhanced renal elimination of circulating solutes compared to the expected baseline.Although patients may present with normal serum c...Objective:Augmented renal clearance(ARC),in contrast to renal dysfunction,refers to enhanced renal elimination of circulating solutes compared to the expected baseline.Although patients may present with normal serum creatinine(Scr)levels,the incidence of ARC is high in intensive care unit(ICU)settings.ARC is associated with subtherapeutic exposure and treatment failure of renally cleared antibiotics.However,limited research exists on the incidence and risk factors of ARC in the ICU,and even fewer data are available specifically for neurological ICU(NICU).This study aims to determine the incidence and risk factors of ARC in neurocritically ill patients.Methods:We retrospectively analyzed all available Scr data of neurocritical care patients admitted to the NICU of the Second Xiangya Hospital of Central South University between December 2020 and January 2023.Creatinine clearance(CrCl)was calculated using the Cockcroft-Gault equation.ARC was defined as a CrCl≥130 mL/(min·1.73 m^(2))sustained for more than 50%of the duration of the NICU stay.A total of 208 neurocritically ill patients were assigned into an ARC group(n=52)and a non-ARC(N-ARC)group(n=156).Clinical characteristics were compared between the 2 groups.Variables with P<0.05 in univariate analysis were included in binary Logistic regression to identify independent risk factors for ARC.Results:The incidence of ARC among neurocritically ill patients was 25.00%.Of the 74 patients with normal CrCl,20(27.03%)gradually developed ARC during hospitalization.Compared with the N-ARC group,the patients of the ARC group were younger(P<0.001),with a higher proportion of females(P=0.048)and a lower admission mean arterial pressure(MAP)(P=0.034).Moreover,patients of the ARC group were commonly complicated with severe bacterial infections compared with the patients of the N-ARC group(P<0.001).In binary Logistic regression analysis,younger age(OR=0.903,95%CI 0.872 to 0.935)and severe bacterial infections(OR=6.270,95%CI 2.568 to 15.310)were significant predictors of ARC.Conclusion:ARC is relatively common in the NICU.A considerable number of patients with initially normal renal function developed ARC during hospitalization.Younger age and concurrent severe bacterial infection are important risk factors of ARC in neurocritically ill patients.展开更多
文摘目的探讨长春西汀联合依达拉奉治疗急性脑梗死的临床效果及对患者神经功能恢复的影响。方法选取2013年1月至2016年12月于本院就诊的急性脑梗死患者232例为研究对象。根据随机数表法将入选患者分为对照组(102例)和观察组(130例),所有患者均行抗血小板聚集、降脂固斑、控制血压、维持水电解质平衡等常规治疗。对照组患者注射依达拉奉,观察组患者在对照组治疗基础上加用长春西汀治疗。治疗1个疗程后比较两组患者脑血流灌注评价指标和血清学指标,出院2个月后随访比较两组患者美国国立卫生研究院卒中量表(National Institute of Health Stroke Scale,NIHSS)评分、格拉斯哥昏迷评分(Glasgow coma score,GCS)及临床疗效。结果治疗后,两组患者NIHSS评分较治疗前均显著降低(P<0.05),GCS较治疗前均显著升高(P<0.05);观察组患者NIHSS评分显著低于对照组(P<0.05),GCS显著高于对照组(P<0.05)。治疗后观察组患者脑血流量(cerebral blood flow,CBF)和脑血容量(cerebral blood volume,CBV)较对照组均显著增加(P<0.001),脑血流平均通过时间(mean transit time,MTT)较对照组显著缩短(P<0.001),神经生长相关蛋白43(growth-associated protein 43,GAP-43)、基质金属蛋白酶(matrix metalloproteinases,MMP)-2、MMP-9、血栓调节蛋白(thrombomodulin,TM)及血小板因子4(platelet factor 4,PF4)含量均显著低于对照组(P<0.05,P<0.001)。观察组患者治疗总有效率显著高于对照组(P<0.05)。结论长春西汀联合依达拉奉治疗急性脑梗死,能够明显改善患者NIHSS评分和GCS,显著增加CBF和CBV,有效缩短脑血流MTT,降低GAP-43、MMP-2、MMP-9、TM、PF4含量,临床治疗效果显著。
基金supported by the Natural Science Foundation of Hunan Province(2023JJ60087)the Clinical Medical Technology Innovation Guidance Project of Hunan Province(2021SK53501),China。
文摘Objective:Augmented renal clearance(ARC),in contrast to renal dysfunction,refers to enhanced renal elimination of circulating solutes compared to the expected baseline.Although patients may present with normal serum creatinine(Scr)levels,the incidence of ARC is high in intensive care unit(ICU)settings.ARC is associated with subtherapeutic exposure and treatment failure of renally cleared antibiotics.However,limited research exists on the incidence and risk factors of ARC in the ICU,and even fewer data are available specifically for neurological ICU(NICU).This study aims to determine the incidence and risk factors of ARC in neurocritically ill patients.Methods:We retrospectively analyzed all available Scr data of neurocritical care patients admitted to the NICU of the Second Xiangya Hospital of Central South University between December 2020 and January 2023.Creatinine clearance(CrCl)was calculated using the Cockcroft-Gault equation.ARC was defined as a CrCl≥130 mL/(min·1.73 m^(2))sustained for more than 50%of the duration of the NICU stay.A total of 208 neurocritically ill patients were assigned into an ARC group(n=52)and a non-ARC(N-ARC)group(n=156).Clinical characteristics were compared between the 2 groups.Variables with P<0.05 in univariate analysis were included in binary Logistic regression to identify independent risk factors for ARC.Results:The incidence of ARC among neurocritically ill patients was 25.00%.Of the 74 patients with normal CrCl,20(27.03%)gradually developed ARC during hospitalization.Compared with the N-ARC group,the patients of the ARC group were younger(P<0.001),with a higher proportion of females(P=0.048)and a lower admission mean arterial pressure(MAP)(P=0.034).Moreover,patients of the ARC group were commonly complicated with severe bacterial infections compared with the patients of the N-ARC group(P<0.001).In binary Logistic regression analysis,younger age(OR=0.903,95%CI 0.872 to 0.935)and severe bacterial infections(OR=6.270,95%CI 2.568 to 15.310)were significant predictors of ARC.Conclusion:ARC is relatively common in the NICU.A considerable number of patients with initially normal renal function developed ARC during hospitalization.Younger age and concurrent severe bacterial infection are important risk factors of ARC in neurocritically ill patients.
